Bernie Sanders may have reached the limits of his pharma pressure campaign; PBM executives invited to testify before House panel

Taking stock of the drug industry, from the lab to the medicine chest

May 20, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Kevin Dietsch/Getty Images STAT+ | Bernie Sanders may have reached the limits of his pharma pressure campaign Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. By Rachel Cohrs Zhang STAT+ | PBM executives invited to testify before House panel Executives at the three major pharmacy benefit manager companies have been invited to testify before a House committee next month. By Rachel Cohrs Zhang STAT+ | BIO lays off 30 employees, including senior leaders The biotech industry's largest trade group up is shaking up its structure and leadership after a new CEO began in March. By John Wilkerson and Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser